GLUE · ISSUER CIK 1826457
Monte Rosa Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Monte Rosa Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $137.28 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 1 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$137.28Insider selling
−$137.28Net open-market
Oct 6, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:05 | Oct 5, 2026 | GLUE | Principal Accounting Officer | S · Sell | $10.56 | −13 | 25,891 | -0% | −$137.28 |